AI proved superior in assessing and diagnosing cardiac function when compared with echocardiogram assessments made by sonographers.
According to Cedars-Sinai investigators and their research published in the peer-reviewed journal Nature, findings are based on a first-of-its-kind, blinded, randomized clinical trial of AI in cardiology led by investigators in the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai.
The results have immediate implications for patients undergoing cardiac function imaging as well as broader implications for the field of cardiac imaging.
The scientists said, this trial offers rigorous evidence that utilizes AI in this novel way can improve the quality and effectiveness of echocardiogram imaging for many patients.
